Stay updated with breaking news from Biodelivery Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- The rising prevalence of autoimmune disorders, immune deficiency disorders, bleeding disorders as well as increasing adoption of plasma protein therapy in neurology and other therapeutic
RALEIGH, NC / ACCESSWIRE / March 23, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today provided
Brokerages expect BioDelivery Sciences International, Inc. (NASDAQ:BDSI – Get Rating) to announce earnings per share (EPS) of $0.08 for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for BioDelivery Sciences International’s earnings. BioDelivery Sciences International posted earnings per share of $0.05 in the same quarter last year, which would […]
Wall Street analysts expect that BioDelivery Sciences International, Inc. (NASDAQ:BDSI – Get Rating) will post sales of $41.84 million for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for BioDelivery Sciences International’s earnings, with estimates ranging from $41.00 million to $42.60 million. BioDelivery Sciences International posted sales of $42.17 million in […]
/PRNewswire/ -- Ademi LLP is investigating BioDelivery Sciences (NASDAQ: BDSI) for possible breaches of fiduciary duty and other violations of law in its...